Back to Alzheimers Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT00416078

NCT00416078
Completed Phase 3

Who may be able to join

Who might be able to join this trial:

  • The patient lives in the community (not in a care home or facility) and is able to get around.
  • The patient has been diagnosed with Alzheimer's disease.
  • The patient is between 50 and 95 years old.
  • The caregiver is between 18 and 90 years old.
  • The patient is currently receiving treatment for Alzheimer's disease.
  • Both the patient and caregiver live within 2 hours of Los Angeles.
  • The caregiver has access to the internet at home.
  • The patient has regular, close contact with their caregiver.

Who may not be able to join:

  • The patient lives in a residential care setting, such as a nursing home or assisted living facility.
  • The patient has no family contact.
  • The patient or caregiver has a sudden illness or an ongoing long-term health condition (confirm with trial site).
  • The patient or caregiver is planning to move away from the area within the next year.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Trial details

Status
Completed
Phase
Phase 3
Sponsor
US Department of Veterans Affairs
Registry
clinicaltrials_gov
Start date
1 August 2007
Est. completion
1 June 2012

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Caregiver Burden From Baseline; Change in Frequency of Patient Problematic Behavioral Patterns From Baseline; Change in Caregiver Negative Reactions to Problematic Behavioral Patterns From Baseline; Change in Caregiver Depression From Baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov